<!doctype html>
<html lang="en">
	<head>
		<meta charset="utf-8">
		<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no">

		<title>reveal.js</title>

		<link rel="stylesheet" href="dist/reset.css">
		<link rel="stylesheet" href="dist/reveal.css">
		<link rel="stylesheet" href="dist/theme/black.css">

		<!-- Theme used for syntax highlighted code -->
		<link rel="stylesheet" href="plugin/highlight/monokai.css">
	</head>
	<body>
		<div class="reveal">
			<div class="slides">
				<section>
					<h2>Diagnostic Limitations for CT Pulmonary Embolism Studies</h2>
					<div>Copied nearly verbatim from Arun Nachiappan MD</div>
				</section>
				<section>
					<h2>Goal</h2>
					<p>Review the various technical factors limiting interpretation of a CT Pulmonary Angiogram</p>
				</section>
				<section>
					<h2>Goal</h2>
					<p><s>Review the various technical factors limiting interpretation of a CT Pulmonary Angiogram</s></p>
					<p>Review the various technical factors limiting interpretation of a CT Pulmonary Angiogram</p>
				</section>
				<section>
					<h2>Objectives</h2>
					<ul>
						<li>Show how a power point presentation could be adapted </li>
						<li>Compare and contrast features of acute and chronic pulmonary embolism, and distinguish those from artifact</li>
						<li>Discuss ancillary findings, and evaluate for right ventricular strain</li>
					</ul>
				</section>
				<section>
					<h2>Overview</h2>
					<ul>
						<li>Pulmonary embolism (PE)</li>
						<li>Pulmonary artery (PA) anatomy</li>
						<li>CT pulmonary angiogram (CTPA) technique</li>
					</ul>
				</section>
				<section>
					<h2>PE</h2>
					<ul>
						<li>Embolization of venous thrombus to a PA</li>
						<li>Usually from proximal lower extremity (LE) deep venous thrombus (DVT)</li>
					</ul>
				</section>
				<section>
					<h2>PE epidemiology</h2>
					<ul>
						<li>Incidence in the US is 112 cases/100,000/year</li>
						<li>Venous thromboembolism (VTE) is 3rd most common acute cardiovascular disease in the world</li>
					</ul>
				</section>
				<section>
					<h2>PE adverse outcomes</h2>
					<ul>
						<li>Death
							<ul>
								<li>Untreated: up to 30%</li>
								<li>Treated with anticoagulation: 2%-11%</li>
							</ul>
						</li>
						<li>Recurrent PE and DVT while on anticoagulant therapy
							<ul>
								<li>6% in first 3 months</li>
							</ul>
						</li>
						<li>Chronic thromboembolic pulmonary hypertension
							<ul>
								<li>1%-4% of acute PE survivors after 3 months to 2 years</li>
							</ul>
						</li>
					</ul>
				</section>
				<section>
					<h2>PA names/levels simplified</h2>
					<ul>
						<li>Central
							<ul>
								<li>Main PA (MPA)</li>
								<li>Right PA (RPA) and Left PA (LPA)</li>
								<li>Right Interlobar PA and Left Interlobar PA</li>
								<li>Lobar level</li>
							</ul>
						</li>
						<li>Peripheral
							<ul>
								<li>Segmental level</li>
								<li>Subsegmental level</li>
							</ul>
						</li>
					</ul>
				</section>
				<section>
					<section>
						<h2>Suboptimal Contrast Opacification</h2>
						<ul>
							<li>ROI on main pulmonary artery <250 HU</li>
							<li>Peripheral pumonary arteries aren't opacified well</li>
						</ul>
					</section>
					<section data-background-iframe="https://www.pacsbin.com/c/WJz2_Na9yu?s=60c7def092f81d03854893fd&i=60c7def092f81d0385489450&ww=1500&wc=-72&an=false&header=false&notes=false"
	          				data-background-interactive
						data-preload>
					</section>
					<section data-background-iframe="https://www.pacsbin.com/c/-1-WhN6qyO?s=60a3cdfbf2de543c8726df74&i=60a3cdfbf2de543c8726dfe8&ww=1642&wc=-405&an=false&header=false&notes=false"
	          				data-background-interactive
						data-preload>
					</section>
				</section>
				<section>
					<section>
						<h2>Pulmonary Motion Artifact</h2>
						<ul>
							<li>Blurry vessels on lung windows in lingula and/or lower lobes</li>
							<li>This can be due to cardiac motion (near the heart) or respiratory motion (near the diaphragm)</li>
						</ul>
					</section>
					<section data-background-iframe="https://www.pacsbin.com/c/Zy2c2Na9yd?s=60c7dbeb92f81d0385489048&i=60c7dbeb92f81d038548906a&ww=1400&wc=-500&an=false&header=false&notes=false"
	          				data-background-interactive
						data-preload>
					</section>
					<section data-background-iframe="https://www.pacsbin.com/c/-1-WhN6qyO?s=60a3cdfbf2de543c8726df74&i=60a3cdfbf2de543c8726e042&ww=1400&wc=-500&an=false&header=false&notes=false"
	          				data-background-interactive
						data-preload>
					</section>
					<section data-background-iframe="https://www.pacsbin.com/c/Zy2c2Na9yd?s=60c7dbeb92f81d0385489048&i=60c7dbeb92f81d038548906a&ww=1400&wc=-500&an=false&header=false&notes=false"
	          				data-background-interactive
						data-preload>
					</section>
					<section data-background-iframe="https://www.pacsbin.com/c/bybjIN65kO?s=60c7dd5192f81d0385489192&i=60c7dd5192f81d03854891ba&ww=1400&wc=-500&an=false&header=false&notes=false"
	          				data-background-interactive
						data-preload>
					</section>
				</section>
				
				<section data-background-iframe="https://www.pacsbin.com/c/-1-WhN6qyO?s=60a3cdfbf2de543c8726df74&i=60a3cdfbf2de543c8726dfe6&ww=1798&wc=-423&an=false&header=false&notes=false"
          				data-background-interactive
					data-preload>
				</section>
				
			</div>
		</div>

		<script src="dist/reveal.js"></script>
		<script src="plugin/notes/notes.js"></script>
		<script src="plugin/markdown/markdown.js"></script>
		<script src="plugin/highlight/highlight.js"></script>
		<script>
			// More info about initialization & config:
			// - https://revealjs.com/initialization/
			// - https://revealjs.com/config/
			Reveal.initialize({
				hash: true,

				// Learn about plugins: https://revealjs.com/plugins/
				plugins: [ RevealMarkdown, RevealHighlight, RevealNotes ]
			});
		</script>
	</body>
</html>
